A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB.
NA Proactive news snapshot: PlantX Life, Thunderbird Entertainment, BioSig Technologies. Planet 13 Holdings, American Eagle Gold UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
PlantX Life Inc (CSE:VEGA) (OTCQB:PLXTF) (FRA:WNT1) announced its charitable partnership with the Squamish Food Bank, commonly known as ‘The Market’, a sustainability non-profit organization in Squamish, British Columbia that provides nutritious food for those in need. PlantX said the new partnership will help further its commitment to both health promotion and sustainability through initiatives aimed at lowering food waste.